ThinkCyte

ThinkCyte, founded in 2016 and headquartered in Japan, stands at the forefront of innovation in the Biotechnology, Health and Wellness, and Life Sciences industries. With the slogan, "Deeper insights, better treatments - a single cell at a time," the company delivers on its mission to revolutionize single-cell analysis. By integrating advanced hardware with cutting-edge machine learning and biotechnology, ThinkCyte provides a platform that accelerates biological discoveries and the development of novel treatments and diagnostics.

The company recently completed a Corporate Round investment on 28 November 2023, securing backing from prominent investor Toyoda Gosei. This financial endorsement underscores the confidence in ThinkCyte's potential to make substantial contributions to biomedical research and treatment development. Overall, ThinkCyte presents a compelling opportunity for investors interested in transformative technologies within the biomedical sector.